Co-developed by pharmacists for pharmacists.
Learning Rheum is a dedicated training and medical education programme, developed in partnership with Rheumatology Pharmacists UK (RPUK).
At Galapagos, we value the input and expertise of healthcare professionals in our quest to go further for our patients. We want to accelerate best practice management for patients with rheumatological conditions and have created Learning Rheum as a new online resource. We want to help enhance your knowledge and expertise in rheumatology and support your continued professional development.
In conversation with different members of the Learning Rheum steering committee, each episode in this series explores how pharmacists can get involved in research to improve services for patients.
This article gives practical advices on medicines shortages and how you can best manage these situations.
This article discusses why pharmacists should develop a portfolio, what options are available and how best to gather the evidence and build the portfolio.
Learning Rheum offers you curated educational resources on competencies important to rheumatology pharmacists.
Meet the Learning Rheum steering committee.
Our Research
Galapagos’ core research areas are inflammatory, fibrotic, and kidney diseases, where our clinical activity is focused across several indications.
GB-RA-NA-202210-00006 | Date of preparation: December 2022
Adverse events should be reported.
For Great Britain, reporting forms and information can be found at yellowcard.mhra.gov.uk or via the Yellow Card app (download from the Apple App Store or Google Play Store).
Adverse events should also be reported to Galapagos via email to DrugSafety.UK.Ireland@glpg.com or 0800 072 7878.
Adverse events should be reported.
For Northern Ireland, reporting forms and information can be found at yellowcard.mhra.gov.uk or via the Yellow Card app (download from the Apple App Store or Google Play Store).
Adverse events should also be reported to Galapagos via email to DrugSafety.UK.Ireland@glpg.com or 0800 072 7878.
Adverse events should be reported.
For the Republic of Ireland, reporting forms and information can be found at www.hpra.ie and can be reported to HPRA on +353 1 6764971.
Adverse events should also be reported to Galapagos via email to DrugSafety.UK.Ireland@glpg.com or 00800 7878 1345.
Galapagos and the Galapagos logo are registered trademarks of Galapagos NV.
© 2022 Galapagos NV. All rights reserved.
GB-IBD-FIL-202208-00005 |
Date of preparation: October 2023
Contact Us
Galapagos Biotech Ltd
148 Belmont Rd, Uxbridge UB8 1QS
medicalinfo@glpg.com
Galapagos and the Galapagos logo are registered trademarks of Galapagos NV.
© 2022 Galapagos NV. All rights reserved.
GB-IBD-FIL-202208-00005 |
Date of preparation: October 2023
Contact Us
Galapagos Biotech Ltd
148 Belmont Rd, Uxbridge UB8 1QS
medicalinfo@glpg.com
© Copyright 2021 Galapagos NV
This link will take you away from the Galapagos website and you will be re-directed to a non-Galapagos website. Galapagos does not accept liability for sites controlled by third-parties.
*By choosing the "Healthcare Professional" option, you affirm your status as a healthcare professional in the UK and Ireland and acknowledge that you will receive promotional information pertaining to prescription-only medicines.
